学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

安倍能之（アベヨシユキ）

研究テーマ	rheumatology, 膠原病
研究業績（論文）	<英文原著> 1.Abe Y., Minowa K., Kogami M., Ando T., Makiyama A., Yamaji K., Tamura N.Avacopan is possibly associated with the improvement of ANCA-associated vasculitis activity without decreasing ANCA titres: a four-case series. Rheumatology, 2023. 2.Abe Y., Kawamata N., Makiyama A., Ashizawa T., Hayashi T., Tamura N.In lupus cystitis, is the urinary tract dilated or obstructed? Immunity, inflammation and disease 11:e777, 2023. 3.Omura S., Kida T., Noma H., Sunaga A., Kusuoka H., Kadoya M., Nakagomi D., Abe Y., Takizawa N., Nomura A., Kukida Y., Kondo N., Yamano Y., Yanagida T., Endo K., Hirata S., Matsui K., Takeuchi T., Ichinose K., Kato M., Yanai R., Matsuo Y., Shimojima Y., Nishioka R., Okazaki R., Takata T., Ito T., Moriyama M., Takatani A., Miyawaki Y., Ito-Ihara T., Yajima N., Kawaguchi T., Fukuda W., Kawahito Y.Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study. Rheumatology, 2023. 4.Kogami M., Abe Y., Ando T., Makiyama A., Yamaji K., Tamura N.Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease. Sci Rep 13:2509, 2023. 5.Kawamata N., Abe Y., Makiyama A., Ashizawa K., Tamura N.PET/CT Reveals Localized Inflammation in the Temporal, Vertebral, and Lower Extremity Arteries in Giant Cell Arteritis. Clinical nuclear medicine 48:276-277, 2023. 6.Shimojima Y., Kishida D., Ichikawa T., Kida T., Yajima N., Omura S., Nakagomi D., Abe Y., Kadoya M., Takizawa N., Nomura A., Kukida Y., Kondo N., Yamano Y., Yanagida T., Endo K., Hirata S., Matsui K., Takeuchi T., Ichinose K., Kato M., Yanai R., Matsuo Y., Nishioka R., Okazaki R., Takata T., Ito T., Moriyama M., Takatani A., Miyawaki Y., Ito-Ihara T., Kawaguchi T., Kawahito Y., Sekijima Y.Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS). Arthritis research & therapy 24:204, 2022. 7.Kogami M., Abe Y., Ando T., Makiyama A., Yamaji K., Tamura N.Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis. Rheumatology, 2022. 8.Asanuma Y., Nozawa K., Matsushita M., Kusaoi M., Abe Y., Yamaji K., Tamura N.Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis. Modern rheumatology / the Japan Rheumatism Association, 2022. 9.Abe Y., Kusaoi M., Tada K., Yamaji K., Tamura N.Efficacy of plasma exchange therapy for diffuse alveolar hemorrhage in patients with microscopic polyangiitis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 26:515-521, 2022. 10.Matsushita Y., Kusaoi M., Hiki M., Murayama G., Abe Y., Nozawa K., Takahashi K., Yamaji K., Tamura N., Naito T.Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection: A retrospective observational study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 25:390-400, 2021. 11.Kogami M., Abe Y., Shimada Y., Hori S., Tada K., Yamaji K., Tamura N.Bacteremia in systemic lupus erythematosus: Risk factors, clinical and microbiological characteristics, and outcomes in the largest single-center retrospective cohort in Japan. Lupus 30:2292-2297, 2021. 12.Abe Y., Tada K., Yamaji K., Tamura N.Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study. Biomed Res Int 2021:8630596, 2021. 13.Abe Y., Saeki K., Dobashi H., Kawakami T., Hayashi T., Kobayashi M., Kaname S., Harigai M., Tamura N.Clinical characteristics and social productivity levels of patients with malignant rheumatoid arthritis based on a nationwide clinical database in Japan: annual survey from 2003 to 2013. Modern rheumatology / the Japan Rheumatism Association 31:621-628, 2021. 14.Abe Y., Yamaji K., Endo Y., Kusaoi M., Nakano S., Yang K. S., Tada K., Tsuda H., Tamura N.Plasma Exchange Therapy to Reduce Mortality in Japanese Patients With Diffuse Alveolar Hemorrhage and Microscopic Polyangiitis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 24:208-214, 2020. 15.Abe Y., Kusaoi M., Tada K., Yamaji K., Tamura N.Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy. Rheumatology 59:767-771, 2020. 16.Abe Y., Harada M., Tada K., Yamaji K., Tamura N.Elevated cerebrospinal fluid levels of total protein in patients with secondary central nervous system vasculitis and giant cell arteritis. Modern rheumatology / the Japan Rheumatism Association 30:1033-1038, 2020. 17.Abe Y., Fujibayashi K., Nishizaki Y., Yanagisawa N., Nojiri S., Kon T., Tada K., Yamaji K., Tamura N.Conventional versus Rapid Glucocorticoid Tapering in Severe Systemic Lupus Erythematosus Patients: A Non-Blind, Randomized Controlled Trial. Acta Med Okayama 74:179-183, 2020. 18.Endo Y., Abe Y., Kawano S., Ando T., Sakamoto K., Tamura N.The Association between Absence of Abdominal Pain and Mortality in Lower Intestinal Perforation in Patients with Autoimmune Rheumatic Diseases. Biomed Res Int 2019:5381453, 2019. 19.Ando T., Abe Y., Endo Y., Tada K., Yamaji K., Tamura N.Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease. Modern rheumatology / the Japan Rheumatism Association 29:656-661, 2019. 20.Abe Y., Fujibayashi K., Nishizaki Y., Yanagisawa N., Nojiri S., Nakano S., Tada K., Yamaji K., Tamura N.Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial. Acta Med Okayama 73:85-89, 2019. 21.Abe Y., Ando T., Matsushita M., Tada K., Yamaji K., Tamura N.Changes in antibody titres in patients with anti-transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis. Rheumatology 58:179-181, 2019. 22.Nakano F., Ueno Y., Suda A., Takanashi M., Yamashita A., Abe Y., Kon T., Miyamoto N., Yamashiro K., Tanaka R., Naito T., Yao T., Tamura N., Hattori N.Fatal ischemic stroke caused by cerebral small arteritis in a patient with giant cell arteritis. J Neurol Sci 391:22-24, 2018. 23.Abe Y., Tada K., Yamaji K., Takasaki Y., Tamura N.Association of five-factor score with the mortality in Japanese patients with polyarteritis nodosa. Modern rheumatology / the Japan Rheumatism Association 28:308-312, 2018. 24.Abe Y., Tamura N., Yang K. S., Matsuoka J., Kon T., Yamaji K., Hashimoto H., Tsuda H., Takasaki Y.Predictive factors for mortality in elderly Japanese patients with severe microscopic polyangiitis: A retrospective single-center study. Modern rheumatology / the Japan Rheumatism Association 27:315-319, 2017. 25.Abe Y., Matsushita M., Tada K., Yamaji K., Takasaki Y., Tamura N.Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis. Rheumatology 56:1492-1497, 2017. 26.Abe Yoshiyuki.Detectable anti-MDA5 antibody before onset of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Modern Rheumatology Case Reports 1:118-121, 2017. 27.Abe Y., Kamachi F., Kawamoto T., Makino F., Ito J., Kojima Y., Moustapha Ael D., Usui Y., Yagita H., Takasaki Y., Okumura K., Akiba H.TIM-4 has dual function in the induction and effector phases of murine arthritis. J Immunol 191:4562-4572, 2013. 28.Makino F., Ito J., Abe Y., Harada N., Kamachi F., Yagita H., Takahashi K., Okumura K., Akiba H.Blockade of CD70-CD27 interaction inhibits induction of allergic lung inflammation in mice. American journal of respiratory cell and molecular biology 47:298-305, 2012. 29.Kawamoto T., Abe Y., Ito J., Makino F., Kojima Y., Usui Y., Ma J., Morimoto S., Yagita H., Okumura K., Takasaki Y., Akiba H.Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cells. Arthritis research & therapy 13:R47, 2011. <和文教科書> 30.日本リウマチ財団, 日本リウマチ学会. リウマチ病学テキスト. 改訂第3版 ed: 南江堂; 2022. 15,591p p. <和文総説> 31.安倍能之.【血管炎の診療update-診断・治療の新展開-】最近のトピックス　臨床個人調査票からみた悪性関節リウマチの変遷. 日本臨床 80:1332-1337, 2022. 32.安倍能之.リウマトイド血管炎. リウマチ科 67:350-359, 2022. 33.安倍能之, 秋葉久弥.TIM-4を標的にした関節炎制御. 臨床免疫・アレルギー科 66:189-193, 2016. 34.安倍能之, 田村直人.全身性血管炎の治療による合併症、続発症とその対策. 呼吸器内科 32:380-386, 2017. 35.安倍能之, 田村直人.中小血管炎の予後. リウマチ科 58:537-542, 2017. 36.安倍能之, 田村直人.【動脈・静脈の疾患(下)-最新の診断・治療動向-】血管炎　小型血管炎　ANCA関連血管炎　顕微鏡的多発血管炎. 日本臨床 75:968-972, 2017. 37.安倍能之, 田村直人.【膠原病　膠原病診療のPearls and Myths】セミナー　実地医療に役立つ膠原病の診断・臓器障害のPearls and Myths　自己免疫関連間質性肺炎の疾患概念と診断. Medical Practice 35:923-928, 2018. 38.安倍能之, 田村直人.【血管炎症候群のupdate】結節性多発動脈炎　ADA deficiencyに関する最新の知見を含めて. リウマチ科 61:530-536, 2019. 39.安倍能之, 田村直人.【血管炎症候群のすべて】多様な血管を首座とする血管炎　悪性関節リウマチ. 臨床放射線 66:1199-1208, 2021. 40.小笠原倫大, 渡邉朋子, 安藤誠一郎, 松平蘭, 山路健, 田村直人, 高崎芳成, 安倍能之, 梁広石, 津田裕士, 菱沼留加, 池田圭吾, 関川巌, 木田一成, 小林茂人, 小田啓介, 山口絢子, 片桐彰, 山田雅人, 土江健太郎, 小沼心, 名切裕.順天堂大学医学部附属病院6施設におけるトシリズマブ投与例のレトロスペクティブ解析. Pharma Medica 29:159-165, 2011. <和文原著> 41.鈴木絢子, 安倍能之, 渡邉崇, 小笠原倫大, 天野浩文, 田村直人, 高崎芳成.成人Still病患者に発症した播種性ノカルジア症の1例. 日本内科学会雑誌 99:1324-1326, 2010.

研究テーマ

rheumatology, 膠原病

研究業績（論文）

<英文原著>
1.Abe Y., Minowa K., Kogami M., Ando T., Makiyama A., Yamaji K., Tamura N.Avacopan is possibly associated with the improvement of ANCA-associated vasculitis activity without decreasing ANCA titres: a four-case series. Rheumatology, 2023.
2.Abe Y., Kawamata N., Makiyama A., Ashizawa T., Hayashi T., Tamura N.In lupus cystitis, is the urinary tract dilated or obstructed? Immunity, inflammation and disease 11:e777, 2023.
3.Omura S., Kida T., Noma H., Sunaga A., Kusuoka H., Kadoya M., Nakagomi D., Abe Y., Takizawa N., Nomura A., Kukida Y., Kondo N., Yamano Y., Yanagida T., Endo K., Hirata S., Matsui K., Takeuchi T., Ichinose K., Kato M., Yanai R., Matsuo Y., Shimojima Y., Nishioka R., Okazaki R., Takata T., Ito T., Moriyama M., Takatani A., Miyawaki Y., Ito-Ihara T., Yajima N., Kawaguchi T., Fukuda W., Kawahito Y.Association between hypogammaglobulinaemia and severe infections during induction therapy in ANCA-associated vasculitis: from J-CANVAS study. Rheumatology, 2023.
4.Kogami M., Abe Y., Ando T., Makiyama A., Yamaji K., Tamura N.Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease. Sci Rep 13:2509, 2023.
5.Kawamata N., Abe Y., Makiyama A., Ashizawa K., Tamura N.PET/CT Reveals Localized Inflammation in the Temporal, Vertebral, and Lower Extremity Arteries in Giant Cell Arteritis. Clinical nuclear medicine 48:276-277, 2023.
6.Shimojima Y., Kishida D., Ichikawa T., Kida T., Yajima N., Omura S., Nakagomi D., Abe Y., Kadoya M., Takizawa N., Nomura A., Kukida Y., Kondo N., Yamano Y., Yanagida T., Endo K., Hirata S., Matsui K., Takeuchi T., Ichinose K., Kato M., Yanai R., Matsuo Y., Nishioka R., Okazaki R., Takata T., Ito T., Moriyama M., Takatani A., Miyawaki Y., Ito-Ihara T., Kawaguchi T., Kawahito Y., Sekijima Y.Hypertrophic pachymeningitis in ANCA-associated vasculitis: a cross-sectional and multi-institutional study in Japan (J-CANVAS). Arthritis research & therapy 24:204, 2022.
7.Kogami M., Abe Y., Ando T., Makiyama A., Yamaji K., Tamura N.Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis. Rheumatology, 2022.
8.Asanuma Y., Nozawa K., Matsushita M., Kusaoi M., Abe Y., Yamaji K., Tamura N.Autoantibodies in lupus nephritis useful in distinguishing proliferative nephritis from membranous nephritis. Modern rheumatology / the Japan Rheumatism Association, 2022.
9.Abe Y., Kusaoi M., Tada K., Yamaji K., Tamura N.Efficacy of plasma exchange therapy for diffuse alveolar hemorrhage in patients with microscopic polyangiitis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 26:515-521, 2022.
10.Matsushita Y., Kusaoi M., Hiki M., Murayama G., Abe Y., Nozawa K., Takahashi K., Yamaji K., Tamura N., Naito T.Combination therapy with plasma exchange and glucocorticoid may be effective for severe COVID-19 infection: A retrospective observational study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 25:390-400, 2021.
11.Kogami M., Abe Y., Shimada Y., Hori S., Tada K., Yamaji K., Tamura N.Bacteremia in systemic lupus erythematosus: Risk factors, clinical and microbiological characteristics, and outcomes in the largest single-center retrospective cohort in Japan. Lupus 30:2292-2297, 2021.
12.Abe Y., Tada K., Yamaji K., Tamura N.Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study. Biomed Res Int 2021:8630596, 2021.
13.Abe Y., Saeki K., Dobashi H., Kawakami T., Hayashi T., Kobayashi M., Kaname S., Harigai M., Tamura N.Clinical characteristics and social productivity levels of patients with malignant rheumatoid arthritis based on a nationwide clinical database in Japan: annual survey from 2003 to 2013. Modern rheumatology / the Japan Rheumatism Association 31:621-628, 2021.
14.Abe Y., Yamaji K., Endo Y., Kusaoi M., Nakano S., Yang K. S., Tada K., Tsuda H., Tamura N.Plasma Exchange Therapy to Reduce Mortality in Japanese Patients With Diffuse Alveolar Hemorrhage and Microscopic Polyangiitis. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 24:208-214, 2020.
15.Abe Y., Kusaoi M., Tada K., Yamaji K., Tamura N.Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy. Rheumatology 59:767-771, 2020.
16.Abe Y., Harada M., Tada K., Yamaji K., Tamura N.Elevated cerebrospinal fluid levels of total protein in patients with secondary central nervous system vasculitis and giant cell arteritis. Modern rheumatology / the Japan Rheumatism Association 30:1033-1038, 2020.
17.Abe Y., Fujibayashi K., Nishizaki Y., Yanagisawa N., Nojiri S., Kon T., Tada K., Yamaji K., Tamura N.Conventional versus Rapid Glucocorticoid Tapering in Severe Systemic Lupus Erythematosus Patients: A Non-Blind, Randomized Controlled Trial. Acta Med Okayama 74:179-183, 2020.
18.Endo Y., Abe Y., Kawano S., Ando T., Sakamoto K., Tamura N.The Association between Absence of Abdominal Pain and Mortality in Lower Intestinal Perforation in Patients with Autoimmune Rheumatic Diseases. Biomed Res Int 2019:5381453, 2019.
19.Ando T., Abe Y., Endo Y., Tada K., Yamaji K., Tamura N.Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease. Modern rheumatology / the Japan Rheumatism Association 29:656-661, 2019.
20.Abe Y., Fujibayashi K., Nishizaki Y., Yanagisawa N., Nojiri S., Nakano S., Tada K., Yamaji K., Tamura N.Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial. Acta Med Okayama 73:85-89, 2019.
21.Abe Y., Ando T., Matsushita M., Tada K., Yamaji K., Tamura N.Changes in antibody titres in patients with anti-transcription intermediary factor 1-gamma antibody-positive idiopathic inflammatory myositis. Rheumatology 58:179-181, 2019.
22.Nakano F., Ueno Y., Suda A., Takanashi M., Yamashita A., Abe Y., Kon T., Miyamoto N., Yamashiro K., Tanaka R., Naito T., Yao T., Tamura N., Hattori N.Fatal ischemic stroke caused by cerebral small arteritis in a patient with giant cell arteritis. J Neurol Sci 391:22-24, 2018.
23.Abe Y., Tada K., Yamaji K., Takasaki Y., Tamura N.Association of five-factor score with the mortality in Japanese patients with polyarteritis nodosa. Modern rheumatology / the Japan Rheumatism Association 28:308-312, 2018.
24.Abe Y., Tamura N., Yang K. S., Matsuoka J., Kon T., Yamaji K., Hashimoto H., Tsuda H., Takasaki Y.Predictive factors for mortality in elderly Japanese patients with severe microscopic polyangiitis: A retrospective single-center study. Modern rheumatology / the Japan Rheumatism Association 27:315-319, 2017.
25.Abe Y., Matsushita M., Tada K., Yamaji K., Takasaki Y., Tamura N.Clinical characteristics and change in the antibody titres of patients with anti-MDA5 antibody-positive inflammatory myositis. Rheumatology 56:1492-1497, 2017.
26.Abe Yoshiyuki.Detectable anti-MDA5 antibody before onset of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease. Modern Rheumatology Case Reports 1:118-121, 2017.
27.Abe Y., Kamachi F., Kawamoto T., Makino F., Ito J., Kojima Y., Moustapha Ael D., Usui Y., Yagita H., Takasaki Y., Okumura K., Akiba H.TIM-4 has dual function in the induction and effector phases of murine arthritis. J Immunol 191:4562-4572, 2013.
28.Makino F., Ito J., Abe Y., Harada N., Kamachi F., Yagita H., Takahashi K., Okumura K., Akiba H.Blockade of CD70-CD27 interaction inhibits induction of allergic lung inflammation in mice. American journal of respiratory cell and molecular biology 47:298-305, 2012.
29.Kawamoto T., Abe Y., Ito J., Makino F., Kojima Y., Usui Y., Ma J., Morimoto S., Yagita H., Okumura K., Takasaki Y., Akiba H.Anti-T cell immunoglobulin and mucin domain-2 monoclonal antibody exacerbates collagen-induced arthritis by stimulating B cells. Arthritis research & therapy 13:R47, 2011.

<和文教科書>
30.日本リウマチ財団, 日本リウマチ学会. リウマチ病学テキスト. 改訂第3版 ed: 南江堂; 2022. 15,591p p.

<和文総説>
31.安倍能之.【血管炎の診療update-診断・治療の新展開-】最近のトピックス　臨床個人調査票からみた悪性関節リウマチの変遷. 日本臨床 80:1332-1337, 2022.
32.安倍能之.リウマトイド血管炎. リウマチ科 67:350-359, 2022.
33.安倍能之, 秋葉久弥.TIM-4を標的にした関節炎制御. 臨床免疫・アレルギー科 66:189-193, 2016.
34.安倍能之, 田村直人.全身性血管炎の治療による合併症、続発症とその対策. 呼吸器内科 32:380-386, 2017.
35.安倍能之, 田村直人.中小血管炎の予後. リウマチ科 58:537-542, 2017.
36.安倍能之, 田村直人.【動脈・静脈の疾患(下)-最新の診断・治療動向-】血管炎　小型血管炎　ANCA関連血管炎　顕微鏡的多発血管炎. 日本臨床 75:968-972, 2017.
37.安倍能之, 田村直人.【膠原病　膠原病診療のPearls and Myths】セミナー　実地医療に役立つ膠原病の診断・臓器障害のPearls and Myths　自己免疫関連間質性肺炎の疾患概念と診断. Medical Practice 35:923-928, 2018.
38.安倍能之, 田村直人.【血管炎症候群のupdate】結節性多発動脈炎　ADA deficiencyに関する最新の知見を含めて. リウマチ科 61:530-536, 2019.
39.安倍能之, 田村直人.【血管炎症候群のすべて】多様な血管を首座とする血管炎　悪性関節リウマチ. 臨床放射線 66:1199-1208, 2021.
40.小笠原倫大, 渡邉朋子, 安藤誠一郎, 松平蘭, 山路健, 田村直人, 高崎芳成, 安倍能之, 梁広石, 津田裕士, 菱沼留加, 池田圭吾, 関川巌, 木田一成, 小林茂人, 小田啓介, 山口絢子, 片桐彰, 山田雅人, 土江健太郎, 小沼心, 名切裕.順天堂大学医学部附属病院6施設におけるトシリズマブ投与例のレトロスペクティブ解析. Pharma Medica 29:159-165, 2011.

<和文原著>
41.鈴木絢子, 安倍能之, 渡邉崇, 小笠原倫大, 天野浩文, 田村直人, 高崎芳成.成人Still病患者に発症した播種性ノカルジア症の1例. 日本内科学会雑誌 99:1324-1326, 2010.

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

安倍 能之（アベ ヨシユキ）

安倍能之（アベヨシユキ）